Project

Back to overview

Effects of the SGLT2 inhibitor empagliflozin in patients with euvolemic and hypervolemic hyponatremia

English title Effects of the SGLT2 inhibitor empagliflozin in patients with euvolemic and hypervolemic hyponatremia
Applicant Monnerat Sophie
Number 199391
Funding scheme MD-PhD fellowships (funded by SNSF)
Research institution Abteilung Endokrinologie, Diabetologie und Metabolismus Universitätsspital Basel
Institution of higher education University of Basel - BS
Main discipline Clinical Endocrinology
Start/End 01.11.2020 - 31.10.2023
Approved amount 188'250.00
Show all

Keywords (3)

Hyponatremia; SGLT2 Inhibitor; Empagliflozin

Responsible applicant and co-applicants

Scientific events

Active participation

Title Type of contribution Title of article or contribution Date Place Persons involved
Alumni Forschungstag Talk given at a conference Osmotic Diurese für die Behandlung der Hyponaträmie 21.08.2021 Basel, Switzerland Monnerat Sophie;


-